Skip to content
55

nicorette kaugummi 4 mg

Worth a look

Shows low returns (0.0%), but brand-locked demand (top 5 brands take 100% of clicks) keeps it on the watch list.

Market size 49Growth 34Conversion 98Competition 8Returns 100Price range 84Avg price 95Brand share 0Review moat 91Quality gap 83

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible16.3%

search→purchase rate — share of searches ending in a sale

Avg price

Incredible€29.92

avg listing price — sweet spot $15–$100

Review moat

Great187.38

avg incumbent reviews — the moat a new listing must climb

Price range

Great€10.10–€46.34

cheapest to priciest tracked listing — scored on the share inside $15–$100

Quality gap

Great4.2★

avg incumbent rating — lower means beatable quality

Market size

Okay€265K

€265K/yr · 54K searches

Growth

Okay+7.2%

90-day search growth — must beat 0% to launch

Competition

Bad90%

top-5 click share — a locked-up shelf

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products capture 90% of clicks — a locked-up shelf that new listings rarely crack.

Brands

4 flat

Sellers

22

Top-5 brand share

100%

Open market

0%

  • Nicorette81%
  • LNEE12%
  • Nicotinell3%
  • EurimPharm Arzneimittel GmbH3%
  • Open — no brand owns it (0%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%€27K20%€53K30%€80K40%€106K101001K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 8 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — +7.2% search growth over the last 90 days.
1K750Spike '24Spike '25Prime Day '25Spike '26SepDecMarJunAugNovMarMay

No pronounced peak months · busiest ÷ quietest = 1.3×

Reviews

What buyers praise and complain about, mined from review topics.

Top return reasons

Geschmack44%
Dosierung33%
Stärke11%
Funktionalität insgesamt11%